Dantafur en es it fr

Categoria

Dantafur Marchi, Dantafur Analoghi

Dantafur Marchi miscela

  • No information avaliable
  • Dantafur Formula chimica

    C8H6N4O5

    Dantafur RX link

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Dantafur FDA foglio

    Dantafur DMS (foglio di materiale di sicurezza)

    Dantafur MSDS

    Dantafur Sintesi di riferimento

    Nessuna informazione disponibile

    Dantafur Peso molecolare

    238.157 g/mol

    Dantafur Temperatura di fusione

    263 oC

    Dantafur H2O Solubilita

    79,5 mg / L

    Dantafur Stato

    Solid

    Dantafur LogP

    -0.04

    Dantafur Forme di dosaggio

    Compressa

    Dantafur Indicazione

    Per il trattamento delle infezioni del tratto urinario

    Dantafur Farmacologia

    Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.

    Dantafur Assorbimento

    Nessuna informazione disponibile

    Dantafur Tossicita

    Nessuna informazione disponibile

    Dantafur Informazioni paziente

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Dantafur Atto interessato organismi

    Gram negativi e alcuni batteri gram-positivi